Clinical Trials

Showing trials with last updates posted in 2021.

NCT03319459 | COMPLETED | PHASE1
44 participants

FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2021-11-22
Start Date:
2018-01-18
Completion:
2020-05-29
Conditions
  • HER2 Positive Gastric Cancer
  • Colorectal Cancer
  • Head and Neck Squamous Cell Carcinoma
  • EGFR Positive Solid Tumor
  • Advanced Solid Tumors
  • HER2-positive Breast Cancer
  • Hepatocellular Carcinoma
  • Non Small Cell Lung Cancer
  • Renal Cell Carcinoma
  • Pancreatic Cancer
  • Melanoma
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page